JP2017504586A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2017504586A5 JP2017504586A5 JP2016538593A JP2016538593A JP2017504586A5 JP 2017504586 A5 JP2017504586 A5 JP 2017504586A5 JP 2016538593 A JP2016538593 A JP 2016538593A JP 2016538593 A JP2016538593 A JP 2016538593A JP 2017504586 A5 JP2017504586 A5 JP 2017504586A5
- Authority
- JP
- Japan
- Prior art keywords
- amd
- binding portion
- monoclonal antibody
- binds
- antibody
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201361915953P | 2013-12-13 | 2013-12-13 | |
| US61/915,953 | 2013-12-13 | ||
| PCT/US2014/070337 WO2015089502A2 (en) | 2013-12-13 | 2014-12-15 | Passive immunization for staphylococcus infections |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2019096593A Division JP6735879B2 (ja) | 2013-12-13 | 2019-05-23 | ブドウ球菌感染に対する受動免疫 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2017504586A JP2017504586A (ja) | 2017-02-09 |
| JP2017504586A5 true JP2017504586A5 (enExample) | 2017-11-30 |
| JP6533226B2 JP6533226B2 (ja) | 2019-06-19 |
Family
ID=53370699
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2016538593A Active JP6533226B2 (ja) | 2013-12-13 | 2014-12-15 | ブドウ球菌感染に対する受動免疫 |
| JP2019096593A Active JP6735879B2 (ja) | 2013-12-13 | 2019-05-23 | ブドウ球菌感染に対する受動免疫 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2019096593A Active JP6735879B2 (ja) | 2013-12-13 | 2019-05-23 | ブドウ球菌感染に対する受動免疫 |
Country Status (10)
| Country | Link |
|---|---|
| US (2) | US10100127B2 (enExample) |
| EP (1) | EP3079720B1 (enExample) |
| JP (2) | JP6533226B2 (enExample) |
| KR (1) | KR102318139B1 (enExample) |
| CN (1) | CN105873609B (enExample) |
| AU (1) | AU2014361821B2 (enExample) |
| BR (1) | BR112016013514B1 (enExample) |
| CA (1) | CA2931001C (enExample) |
| ES (2) | ES2754209T3 (enExample) |
| WO (1) | WO2015089502A2 (enExample) |
Families Citing this family (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP3252076B1 (en) | 2011-01-14 | 2019-09-04 | The Regents Of The University Of California | Diagnostic use of antibodies against ror-1 protein |
| US10940204B2 (en) | 2015-07-31 | 2021-03-09 | Research Institute At Nationwide Children's Hospital | Peptides and antibodies for the removal of biofilms |
| EP3365027B1 (en) | 2015-10-14 | 2022-03-30 | Research Institute at Nationwide Children's Hospital | Hu specific antibodies and their use in inhibiting biofilm |
| AU2018206560B9 (en) * | 2017-01-04 | 2025-04-03 | Research Institute At Nationwide Children's Hospital | Antibody fragments for the treatment of biofilm-related disorders |
| EP3600358A1 (en) * | 2017-03-31 | 2020-02-05 | Acell, Inc. | Extracellular matrix compositions with bactericidal or bacteriostatic characteristics useful for protecting and treating patients with bacterial infections |
| CA3145385A1 (en) | 2019-07-08 | 2021-01-14 | Steven D. Goodman | Antibody compositions for disrupting biofilms |
| CA3204730A1 (en) * | 2021-01-15 | 2022-07-21 | Gowrishankar MUTHUKRISHNAN | Staphylococcus aureus antigen-based nucleic acid vaccines |
| EP4108197A1 (en) | 2021-06-24 | 2022-12-28 | Gradient Denervation Technologies | Systems for treating tissue |
| CN119998318A (zh) * | 2022-04-08 | 2025-05-13 | D2M生物治疗有限公司 | 抗mica/b抗体及其用途 |
| CN115925947B (zh) * | 2022-09-27 | 2023-08-22 | 上海百英生物科技股份有限公司 | 一种亲和力成熟方法及抗人pd-l1单域抗体的亲和力成熟 |
| WO2026145542A1 (zh) * | 2024-12-30 | 2026-07-09 | 康源博创生物科技(北京)有限公司 | 一种多肽以及包含其的抗体 |
| CN120425066B (zh) * | 2025-05-06 | 2025-10-28 | 中国农业科学院北京畜牧兽医研究所 | 一种与羊种布鲁氏菌复方新诺明耐药性相关的分子标记及其应用 |
Family Cites Families (21)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4237224A (en) | 1974-11-04 | 1980-12-02 | Board Of Trustees Of The Leland Stanford Jr. University | Process for producing biologically functional molecular chimeras |
| US4816567A (en) | 1983-04-08 | 1989-03-28 | Genentech, Inc. | Recombinant immunoglobin preparations |
| GB8823869D0 (en) | 1988-10-12 | 1988-11-16 | Medical Res Council | Production of antibodies |
| ES2246502T3 (es) | 1990-08-29 | 2006-02-16 | Genpharm International, Inc. | Animales no humanos transgenicos capaces de producir anticuerpos heterologos. |
| US5661016A (en) | 1990-08-29 | 1997-08-26 | Genpharm International Inc. | Transgenic non-human animals capable of producing heterologous antibodies of various isotypes |
| US5625126A (en) | 1990-08-29 | 1997-04-29 | Genpharm International, Inc. | Transgenic non-human animals for producing heterologous antibodies |
| US5545806A (en) | 1990-08-29 | 1996-08-13 | Genpharm International, Inc. | Ransgenic non-human animals for producing heterologous antibodies |
| US5633425A (en) | 1990-08-29 | 1997-05-27 | Genpharm International, Inc. | Transgenic non-human animals capable of producing heterologous antibodies |
| DE69129154T2 (de) | 1990-12-03 | 1998-08-20 | Genentech, Inc., South San Francisco, Calif. | Verfahren zur anreicherung von proteinvarianten mit geänderten bindungseigenschaften |
| US6596509B1 (en) | 1998-07-10 | 2003-07-22 | Cornell Research Foundation, Inc. | Recombinant constructs and systems for secretion of proteins via type III secretion systems |
| FR2871237B1 (fr) | 2004-06-08 | 2011-03-11 | Abag | Nouveaux polypeptides pour la mise en evidence in vitro et la prevention des infections staphylococciques sur protheses articulaires et autres materiels etrangers implantes |
| ES2730275T3 (es) | 2004-09-22 | 2019-11-11 | Glaxosmithkline Biologicals Sa | Composición inmunógena para uso en vacunación contra estafilococos |
| DK2027155T3 (en) | 2006-06-06 | 2016-05-09 | Crucell Holland Bv | HUMAN BINDING MOLECULES with killer activity against staphylococci and uses thereof |
| ZA200904022B (en) | 2006-12-08 | 2010-08-25 | Lexicon Pharmaceuticals Inc | Monoclonal antibodies against ANGPTL3 |
| US8101190B2 (en) | 2009-03-03 | 2012-01-24 | Ingen Biosciences | Method for diagnosing staphylococcal infections |
| EP2419129A2 (en) | 2009-04-14 | 2012-02-22 | Novartis AG | Compositions for immunising against staphylococcus aerus |
| US8580714B2 (en) | 2009-10-14 | 2013-11-12 | Janssen Biotech, Inc. | Methods of affinity maturing antibodies |
| EP2566891B1 (en) * | 2010-05-03 | 2016-11-02 | University Of Rochester | Anti-glucosaminidase passive immunization for staphylococcus aureus infections |
| CN101979089A (zh) * | 2010-11-17 | 2011-02-23 | 赤峰博恩药业有限公司 | 奶牛金黄色葡萄球菌乳房炎灭活疫苗及其制备方法 |
| CA2853943C (en) | 2011-11-02 | 2015-12-08 | University Of Rochester | Anti-glucosaminidase passive immunization for staphylococcus aureus infections |
| CN102890153A (zh) * | 2012-05-24 | 2013-01-23 | 天津兰瑞生物技术有限公司 | 脂磷壁酸elisa检测试剂盒及其制备技术 |
-
2014
- 2014-12-12 ES ES14869474T patent/ES2754209T3/es active Active
- 2014-12-12 BR BR112016013514-8A patent/BR112016013514B1/pt active IP Right Grant
- 2014-12-15 CN CN201480067873.2A patent/CN105873609B/zh active Active
- 2014-12-15 KR KR1020167015659A patent/KR102318139B1/ko active Active
- 2014-12-15 CA CA2931001A patent/CA2931001C/en active Active
- 2014-12-15 EP EP14870387.9A patent/EP3079720B1/en active Active
- 2014-12-15 AU AU2014361821A patent/AU2014361821B2/en active Active
- 2014-12-15 WO PCT/US2014/070337 patent/WO2015089502A2/en not_active Ceased
- 2014-12-15 JP JP2016538593A patent/JP6533226B2/ja active Active
- 2014-12-15 US US15/104,104 patent/US10100127B2/en active Active
- 2014-12-15 ES ES14870387T patent/ES2822590T3/es active Active
-
2018
- 2018-10-15 US US16/160,880 patent/US10577431B2/en active Active
-
2019
- 2019-05-23 JP JP2019096593A patent/JP6735879B2/ja active Active
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP6735879B2 (ja) | ブドウ球菌感染に対する受動免疫 | |
| Stewart et al. | Vancomycin-modified implant surface inhibits biofilm formation and supports bone-healing in an infected osteotomy model in sheep: a proof-of-concept study | |
| Wolford et al. | Management of the infected temporomandibular joint total joint prosthesis | |
| JP2013533210A5 (enExample) | ||
| Simon et al. | Immediate reconstruction of the mandible after resection for aggressive odontogenic tumours: a cohort study | |
| CA2797121A1 (en) | Anti-glucosaminidase passive immunization for staphylococcus aureus infections | |
| Aslam et al. | Risk factors for subsequent diagnosis of prosthetic joint infection | |
| JP2015517496A (ja) | バイオフィルム形成を防止する方法 | |
| WO2022174009A1 (en) | Antibodies that bind glucosaminidase and uses thereof | |
| WO2025106896A1 (en) | Coating of medical and implant biomaterials with an anti-biofilm agent to prevent and treat infection | |
| Cajas-Monson et al. | A 73-year-old woman with delayed intra-abdominal and systemic sepsis following complicated aortobifemoral bypass | |
| Pawar | Influence of Negative Pressure Wound Therapy and Surface Topography on Soft-Tissue Responses Around Percutaneous Devices | |
| Arai et al. | IV–3 treatment-targeting based on ultrasonographic examination can improve LIPUS treatment results in delayed union | |
| Herbert | Surgical debridement with early skin grafting in the management of a complex diabetic foot wound | |
| Nayyar | Dental implant placement procedure with simultaneous bone augmentation: The Pros and Cons, A Case Report | |
| AU2013259786A1 (en) | Methods for preventing biofilm formation | |
| Gacon et al. | Infected total knee replacements | |
| Watanabe et al. | IV–4 Acceleration of Tibial Open and/or Comminuted Fracture Healing by Low-Intensity Pulsed Ultrasound (LIPUS); A Retrospective Cohort Study | |
| Fattouh et al. | Comparison of Different Surgical Protocols in Management of Medication-Related Osteonecrosis of the Jaw Using Platelet-Rich Fibrin and Bone Morphogenetic PROTEIN-2 | |
| Winkler | Treatment of Orthopedic Infections: Addressing the Biofilm Issue | |
| Uchiyama et al. | IV–2 A Femoral Targeting Method Using Ultrasonography for Low-Intensity Pulsed Ultrasound (LIPUS) Treatment After Intramedullary Nailing | |
| Katagiri et al. | III–2 LIPUS Treatment for Periprosthetic Fractures Following Bipolar Hip Arthroplasty: Report of Two Cases | |
| Hidaka et al. | I–3 Bisphosphonate-Related Osteonecrosis of the Jaw (BRONJ): Prevention by Low-Intensity Pulsed Ultrasound (LIPUS) in a Rat Model | |
| Matsumoto et al. | III–4 Treatment with Low-Intensity Pulsed Ultrasound (LIPUS) for Open Fracture and Comminuted Fracture | |
| Kusuyama et al. | I–2 Osteoblast Responses to Low-Intensity Pulsed Ultrasound (LIPUS) are Attenuated by Osteopontin Expression |